tiprankstipranks
AnaptysBio Inc (MX:ANAB)
:ANAB
Mexico Market

AnaptysBio (ANAB) Ratios

0 Followers

AnaptysBio Ratios

MX:ANAB's free cash flow for Q1 2026 was $0.98. For the 2026 fiscal year, MX:ANAB's free cash flow was decreased by $ and operating cash flow was $-1.25. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
7.58 9.07 9.51 10.87 17.16
Quick Ratio
7.58 9.07 9.51 10.87 17.16
Cash Ratio
5.96 6.17 2.71 0.96 2.74
Solvency Ratio
-0.08 -0.03 -0.35 -0.45 -0.36
Operating Cash Flow Ratio
0.11 0.51 -2.98 -3.23 -2.82
Short-Term Operating Cash Flow Coverage
2.11 0.00 -70.30 0.00 0.00
Net Current Asset Value
$ -828.00K$ 23.07M$ 18.91M$ 42.55M$ 98.92M
Leverage Ratios
Debt-to-Assets Ratio
0.84 0.04 0.76 0.04 0.03
Debt-to-Equity Ratio
21.76 0.38 5.21 0.20 0.07
Debt-to-Capital Ratio
0.96 0.27 0.84 0.17 0.07
Long-Term Debt-to-Capital Ratio
0.95 0.24 0.83 0.00 0.00
Financial Leverage Ratio
25.86 9.79 6.83 5.13 2.33
Debt Service Coverage Ratio
0.69 0.86 -1.78 -8.65 -4.99
Interest Coverage Ratio
0.49 0.60 -2.29 -9.09 -5.46
Debt to Market Cap
0.16 0.01 1.42 0.00 0.00
Interest Debt Per Share
12.55 3.38 14.78 1.33 1.44
Net Debt to EBITDA
0.49 -3.24 -2.66 0.12 0.49
Profitability Margins
Gross Profit Margin
116.42%98.97%-79.49%-671.01%-763.21%
EBIT Margin
24.13%28.48%-104.23%-915.50%-1045.90%
EBITDA Margin
25.17%29.52%-101.60%-911.70%-1023.20%
Operating Profit Margin
17.56%20.42%-125.93%-958.27%-1119.41%
Pretax Profit Margin
-11.46%-5.57%-159.10%-953.68%-1251.09%
Net Profit Margin
-11.53%-5.64%-159.10%-953.66%-1251.33%
Continuous Operations Profit Margin
-11.53%-5.64%-159.10%-953.66%-1251.33%
Net Income Per EBT
100.60%101.25%100.00%100.00%100.02%
EBT Per EBIT
-65.27%-27.28%126.34%99.52%111.76%
Return on Assets (ROA)
-8.13%-3.63%-30.02%-36.17%-21.09%
Return on Equity (ROE)
442.91%-35.56%-204.93%-185.71%-49.11%
Return on Capital Employed (ROCE)
14.17%14.70%-26.22%-39.62%-19.71%
Return on Invested Capital (ROIC)
14.06%14.61%-26.11%-39.45%-19.65%
Return on Tangible Assets
-8.13%-3.63%-30.02%-36.17%-21.09%
Earnings Yield
-1.68%-1.47%-57.95%-28.37%-14.75%
Efficiency Ratios
Receivables Turnover
9.03 6.93 2.24 2.50 7.25
Payables Turnover
-5.07 0.63 40.94 28.16 31.90
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
17.45 16.89 5.62 0.94 0.51
Asset Turnover
0.70 0.64 0.19 0.04 0.02
Working Capital Turnover Ratio
0.79 0.67 0.24 0.04 0.02
Cash Conversion Cycle
112.36 -530.46 154.09 132.79 38.90
Days of Sales Outstanding
40.44 52.66 163.01 145.75 50.35
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
-71.92 583.13 8.92 12.96 11.44
Operating Cycle
40.44 52.66 163.01 145.75 50.35
Cash Flow Ratios
Operating Cash Flow Per Share
0.16 0.71 -4.77 -4.49 -2.61
Free Cash Flow Per Share
0.15 0.71 -4.78 -4.52 -2.63
CapEx Per Share
<0.01 <0.01 0.01 0.03 0.01
Free Cash Flow to Operating Cash Flow
0.98 1.00 1.00 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
64.90 226.40 -378.04 -149.69 -205.57
Capital Expenditure Coverage Ratio
64.90 226.40 -378.04 -149.69 -205.57
Operating Cash Flow Coverage Ratio
0.02 1.40 -0.37 -6.78 -3.78
Operating Cash Flow to Sales Ratio
0.02 0.08 -1.48 -7.04 -7.15
Free Cash Flow Yield
0.27%2.18%-54.15%-21.09%-8.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-64.02 -70.26 -1.72 -3.52 -6.78
Price-to-Sales (P/S) Ratio
7.10 3.83 2.75 33.61 84.85
Price-to-Book (P/B) Ratio
125.37 24.14 3.54 6.55 3.33
Price-to-Free Cash Flow (P/FCF) Ratio
374.05 45.80 -1.85 -4.74 -11.80
Price-to-Operating Cash Flow Ratio
356.88 45.60 -1.85 -4.77 -11.86
Price-to-Earnings Growth (PEG) Ratio
0.20 0.77 0.11 -0.11 -0.06
Price-to-Fair Value
125.37 24.14 3.54 6.55 3.33
Enterprise Value Multiple
28.69 9.73 -5.36 -3.57 -7.80
Enterprise Value
1.68B 674.06M 497.00M 558.56M 820.98M
EV to EBITDA
28.69 9.73 -5.36 -3.57 -7.80
EV to Sales
7.22 2.87 5.44 32.56 79.81
EV to Free Cash Flow
380.60 34.37 -3.66 -4.59 -11.10
EV to Operating Cash Flow
374.74 34.22 -3.67 -4.62 -11.16
Tangible Book Value Per Share
0.44 1.34 2.50 3.27 9.31
Shareholders’ Equity Per Share
0.44 1.34 2.50 3.27 9.31
Tax and Other Ratios
Effective Tax Rate
>-0.01 -0.01 >-0.01 <0.01 >-0.01
Revenue Per Share
8.10 8.44 3.22 0.64 0.37
Net Income Per Share
-0.93 -0.48 -5.12 -6.08 -4.57
Tax Burden
1.01 1.01 1.00 1.00 1.00
Interest Burden
-0.47 -0.20 1.53 1.04 1.20
Research & Development to Revenue
0.55 0.58 1.79 8.14 8.63
SG&A to Revenue
0.27 0.22 0.46 2.44 3.56
Stock-Based Compensation to Revenue
0.18 0.15 0.37 1.94 2.66
Income Quality
-0.17 0.40 0.93 0.74 0.57
Currency in USD